You are required to be logged in to access the full website
Click here if you have forgotten your username or password
8 April 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Tuesday that it has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Dapaglifloz...
8 April 2026 - Biopharmaceutical company Insmed Incorporated (Nasdaq:INSM) disclosed on Tuesday that the Phase 2b CEDAR study, which evaluated brensocatib in adult patients with moderate to severe hidradenitis suppurativa (HS), did not meet its prima...
8 April 2026 - Dexcel Pharma USA, a subsidiary of Israeli pharmaceutical company Dexcel Pharma, announced on Tuesday that it has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) fo...
7 April 2026 - US biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Tuesday that it has entered into a definitive agreement to acquire Tubulis GmbH, a German clinical-stage biotechnology company focused on next-generation antib...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe